| Date | Name | Title | Action | No Shares | Price Per Share |
|---|---|---|---|---|---|
Insider Transactions For AORT | |||||
| 2025-11-13 | Horton, Amy | VP, Chief Accounting Officer | Sold | 3482 | $45.86 |
| 2025-11-13 | Holloway, Jean F | SVP, General Counsel | Sold | 5761 | $45.86 |
| 2025-11-13 | Mackin, James P | President & CEO | Sold | 34210 | $45.86 |
| 2025-11-13 | Davis, John E | Chief Commercial Officer | Sold | 6563 | $45.86 |
| 2025-11-13 | Stanton, Marshall S. | SVP, Clinical & MD Affair | Sold | 4993 | $45.86 |
| 2025-11-11 | Holloway, Jean F | SVP, General Counsel | Sold | 10000 | $46.18 |
| 2025-11-11 | Holloway, Jean F | SVP, General Counsel | Purchased | 10000 | $11.03 |
| 2025-11-11 | Holloway, Jean F | SVP, General Counsel | Sold | 10000 | $0.00 |
| 2025-11-10 | Horton, Amy | VP, Chief Accounting Officer | Sold | 1789 | $44.62 |
| 2025-11-10 | Stanton, Marshall S. | SVP, Clinical & MD Affair | Sold | 2566 | $44.62 |
| 2025-11-10 | Holloway, Jean F | SVP, General Counsel | Sold | 2960 | $44.62 |
| 2025-11-10 | Mackin, James P | President & CEO | Sold | 17580 | $44.62 |
| 2025-11-10 | Davis, John E | Chief Commercial Officer | Sold | 3373 | $44.62 |
| 2025-08-27 | Stanton, Marshall S. | SVP, Clinical & MD Affair | Purchased | 18200 | $11.03 |
| 2025-08-27 | Stanton, Marshall S. | SVP, Clinical & MD Affair | Sold | 18200 | $44.02 |
| 2025-08-27 | Stanton, Marshall S. | SVP, Clinical & MD Affair | Sold | 18200 | $0.00 |
| 2025-08-25 | Holloway, Jean F | SVP, General Counsel | Sold | 10000 | $44.37 |
| 2025-08-25 | Holloway, Jean F | SVP, General Counsel | Purchased | 10000 | $11.03 |
| 2025-08-25 | Holloway, Jean F | SVP, General Counsel | Sold | 10000 | $0.00 |
| 2025-08-15 | Mackin, James P | President & CEO | Sold | 12500 | $42.32 |